A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancer

被引：0
|
作者：
Ramesh K. Ramanathan
Joel Picus
Haralambos Raftopoulos
Stephen Bernard
A. Craig Lockhart
Gary Frenette
John Macdonald
Susan Melin
Daniel Berg
Frank Brescia
Howard Hochster
Allen Cohn
机构：
[1] University of Pittsburgh School of Medicine,Division of Hematology/Oncology, Department of Medicine
[2] Washington School of Medicine,Department of Internal Medicine, Division of Hematology/Oncology
[3] Columbia University Medical Center,undefined
[4] University of North Carolina,undefined
[5] Chapel Hill,undefined
[6] Vanderbilt University Medical Center,undefined
[7] Carolinas Hematology–Oncology Associates,undefined
[8] Saint Vincent’s Comprehensive Cancer Center,undefined
[9] Aptium Oncology,undefined
[10] Wake Forest University,undefined
[11] University of Iowa,undefined
[12] Medical University of South Carolina,undefined
[13] New York University School of Medicine,undefined
[14] Rocky Mountain Cancer Center,undefined
[15] UPMC Cancer Pavilion,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 61卷
关键词：
Colorectal cancer; Phase II; Milataxel; MAC-321; Taxanes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：453 / 458
页数：5
相关论文
共 50 条
  • [21] Phase II study of weekly high dose fluorouracil in previously treated patients with metastatic colorectal cancer
    Mermershtain, W
    Lavrenkov, K
    Cohen, Y
    JOURNAL OF CHEMOTHERAPY, 2000, 12 (02) : 183 - 185
  • [22] Bevacizumab in patients with previously treated metastatic colorectal cancer: preliminary results of a phase II study (bevacolor)
    Borg, C.
    Delord, J. P.
    Husseini, F.
    Lenoir, V. Trillet
    Faroux, R.
    Francois, E.
    Ychou, M.
    Bergougnoux, L.
    Bennouna, J.
    Douillard, J. Y.
    EJC SUPPLEMENTS, 2007, 5 (04): : 257 - 257
  • [23] Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancer
    S. M. Reddy
    S. Kopetz
    J. Morris
    N. Parikh
    W. Qiao
    M. J. Overman
    D. Fogelman
    I. Shureiqi
    C. Jacobs
    Z. Malik
    C. A. Jimenez
    R. A. Wolff
    J. L. Abbruzzese
    G. Gallick
    C. Eng
    Investigational New Drugs, 2015, 33 : 977 - 984
  • [24] Phase II study of capecitabine, oxaliplatin and erlotinib in previously treated patients with metastatic colorectal cancer (MCRC).
    Meyerhardt, JA
    Xhu, A
    Enzinger, PC
    Ryan, DP
    Clark, JW
    Kulke, MH
    Michelini, A
    Vincitore, M
    Thomas, A
    Fuchs, CS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 265S - 265S
  • [25] A multicenter phase II study of cabozantinib plus nivolumab for patients (pts) with advanced angiosarcoma (AS) previously treated with a taxane (Alliance A091902)
    Grilley-Olson, Juneko E.
    Allred, Jacob B.
    Schuetze, Scott
    Davis, Elizabeth J.
    Wagner, Michael J.
    Poklepovic, Andrew Stewart
    Waechter, Blake
    Riedel, Richard F.
    Welliver, Meng Xu
    Berg, Stephanie A.
    George, Suzanne
    Robinson, Steven Ian
    Googe, Paul B.
    D'Angelo, Sandra P.
    Schwartz, Gary K.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] A phase II trial of the epothilone B analog, BMS-247550, in patients with previously treated advanced colorectal cancer
    Eng, C
    Kindler, HL
    Nattam, S
    Ansari, RH
    Kasza, K
    Wade-Oliver, K
    Vokes, EE
    ANNALS OF ONCOLOGY, 2004, 15 (06) : 928 - 932
  • [27] Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
    Vahdat, Linda T.
    Pruitt, Brian
    Fabian, Carol J.
    Rivera, Ragene R.
    Smith, David A.
    Tan-Chiu, Elizabeth
    Wright, Jonathan
    Tan, Antoinette R.
    DaCosta, Noshir A.
    Chuang, Ellen
    Smith, John
    O'Shaughnessy, Joyce
    Shuster, Dale E.
    Meneses, Nicole L.
    Chandrawansa, Kumari
    Fang, Fang
    Cole, Patricia E.
    Ashworth, Simon
    Blum, Joanne L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18) : 2954 - 2961
  • [28] Phase II study of taxotere monotherapy in previously treated patients (pts) with advanced breast cancer (ABC)
    Alexopoulos, CG
    Rigatos, G
    Efremidou, A
    Papacharalambous, A
    Alexopoulos, A
    Vasilomanolakis, M
    Patila, E
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 680 - 680
  • [29] Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: A phase II study
    Brugnatelli, S
    Riccardi, A
    Danova, M
    Pugliese, P
    Tinelli, C
    Luchena, G
    Bernardo, A
    Giardina, G
    Fava, S
    Montanari, G
    Pedrotti, C
    Poli, AM
    ONCOLOGY REPORTS, 2001, 8 (04) : 801 - 805
  • [30] Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane
    Satake, Hironaga
    Sagawa, Tamotsu
    Fujikawa, Koshi
    Hatachi, Yukimasa
    Yasui, Hisateru
    Kotaka, Masahito
    Kato, Takeshi
    Tsuji, Akihito
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (05) : 839 - 845
12345